Dynavax Technologies Corporation (DVAX) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $16.70, down from yesterday’s close by -13.70%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Dynavax Technologies Corporation (DVAX) currently trades with a market capitalization of $854.71 Million. That value represents a market adjusting for revenues that have been growing by 11.49 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$83.47 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of -$0.49 on a per share basis this quarter. Perhaps, that suggests something about why 2.10% of the outstanding share supply is held by institutional investors.
Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Dynavax Technologies Corporation recorded a 52-week high of $24.45. It is now trading 7.75% off that level. The stock is trading $18.26 its 50-day moving average by 1.56%. The stock carved out a 52-week low down at $5.35.
In recent action, Dynavax Technologies Corporation (DVAX) has made a move of -10.70% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 15.08, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange.